Stay updated on Epacadostat Combination in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Combination in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat Combination in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical trial record for the epacadostat and pembrolizumab study is displayed, with study details, results measures, record history, publications, and supporting documents.SummaryDifference85%

- Check18 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0 on the 403 Forbidden page.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH banner announces transition updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence.” The page’s study-record area still displays a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision changed from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe study page now shows a 403 error instead of the study details, representing an access issue that hides the record and related content.SummaryDifference23%

Stay in the know with updates to Epacadostat Combination in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Combination in Advanced Solid Tumors Clinical Trial page.